Agape ATP Corp (ATPC): Nasdaq/NYSE listing notice — Agape ATP receives Nasdaq minimum bid price non-compliance notice; 180-day cure period until July 27, 2026

Agape ATP Corp

Received Nasdaq notice Jan 27, 2026 for failing $1.00 minimum bid price based on closing bid Dec 10, 2025–Jan 26, 2026.
Initial 180-day compliance period expires July 27, 2026; possible additional 180 days if eligible.
Company evaluating options, including potential reverse stock split, to regain compliance.
No immediate delisting; stock continues trading on Nasdaq under symbol ATPC.
If not cured, securities may be delisted; no assurance of regaining compliance.

item 3.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

Agape ATP Corp received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: minimum bid price
Rules: 5550(a)(2)

Exact text from the filing

January 27, 2026, Agape ATP Corporation (the “Company”) received a letter from the Listing Qualifications staff of The Nasdaq Stock Market (“Nasdaq”) notifying the Company that based on the closing bid price of the Company for the period from December 10, 2025 to January 26, 2026, the Company no longer meets the continued listing requirement of Nasdaq under Nasdaq Listing Rules 5550(a)(2), to maintain a minimum bid price of $1 per share. Nasdaq has provided the Company with an 180 calendar days compliance period, or until July 27, 2026, in which to regain compliance with Nasdaq continued listi

View on SEC.gov

5 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

Agape ATP Corp filing history →

Source: SEC EDGAR

accession 0001493152-26-004150

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.